Drugs A - Z

dofetilide Images

Generic Name: dofetilide

Brand Names: Tikosyn

There is an FDA Alert for this drug. Click here to view it.

Because of the arrhythmogenic potential, hospitalize and monitor closely (provision of Clcr calculations, continuous ECG monitoring, and cardiac resuscitation) patients for 3 days during treatment initiation. (See Arrhythmogenic Effects under Cautions.) Clinicians and pharmacies in institutions must confirm their participation in a designated Tikosyn® educational program before prescribing or ordering the drug. (See General under Dosage and Administration.)


FDA approved a REMS for dofetilide to ensure that the benefits of a drug outweigh the risks. The REMS may apply to one or more preparations of dofetilide and consists of the following: medication guide, elements to assure safe use, and implementation system. See the FDA REMS page ([Web]) or the ASHP REMS Resource Center ([Web]).

The Healthline Site, its content, such as text, graphics, images, search results, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.